3Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous systemREVIEWS1309-1312
4Dendritic shrinkage after injury: a cellular killer or a necessity for axonal regeneration?REVIEWS1313-1316
7Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's diseaseREVIEWS1330-1334
9Therapeutic strategies for peripheral nerve injury: decellularized nerve conduits and Schwann cell transplantationREVIEWS1343-1351
10Role and prospects of regenerative biomaterials in the repair of spinal cord injuryREVIEWS1352-1363
11The "Brain Stress Timing" phenomenon and other misinterpretations of randomized clinical trial on aneurysmal subarachnoid hemorrhageREVIEWS1364-1366
13Insights into ligand expression heterogeneity across multiple cell types in the adult forebrain that regulates neural stem cell behaviorPERSPECTIVES1369-1371
14Translational perspective: is cinnamon a suitable agent for cognitive impairment and Alzheimer's disease associated with brain trauma?PERSPECTIVES1372-1373
15Soluble neuregulin-1 (NRG 1): a factor promoting peripheral nerve regeneration by affecting Schwann cell activity immediately after injuryPERSPECTIVES1374-1375
20Compartmentalized necroptosis activation in excitotoxicity-induced axonal degeneration: a novel mechanism implicated in neurodegenerative disease pathologyPERSPECTIVES1385-1386
